4 lessons learned from conducting virtual trials: A sit-down with Iqvia

By Melissa Fassbender contact

- Last updated on GMT

Related tags: IQVIA, Virtual clinical trials, Remote clinical trials, Decentralized trials, Contract research, Wearables, Protocol development

It’s a lot more complicated than a simple technology – says Iqvia global head of virtual trials, who shares four lessons learned during a discussion at the company’s headquarters in Research Triangle Park.

Josh Rose is the Vice President of Clinical Development Strategy and Innovation, and the Global Head Virtual Trial Operations at Iqvia.

To discuss the company’s lessons learned from conducting virtual trials, Outsourcing-Pharma went to the source and sat down with Rose at Iqvia’s headquarters in Durham, NC.

Speaking to the complexity of running a trial with this model, Rose said “being cutting edge is not enough.” ​It’s important to start early, “embed virtual thinking into your protocol,” ​he added, addressing four key areas to keep in mind.

For the full discussion, watch the video above.

Related news

Show more

Related products

show more

The Essential Clinical Development Resource Center

The Essential Clinical Development Resource Center

Data Management Solution Center | 05-Mar-2020 | Data Sheet

Clinical trials are becoming increasingly complex with oversight workloads increasing too. A recent survey based study conducted by Medidata in association...

Infographic:Transforming Data Capture & Management

Infographic:Transforming Data Capture & Management

Data Management Solution Center | 05-Mar-2020 | Infographic

Is your clinical study's data capture and management processes efficient? Medidata Rave Clinical Cloud is the only industry platform that creates...

Electronic Informed Consent and Global Regulation

Electronic Informed Consent and Global Regulation

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Medidata is conducting an on-going study to understand global regulatory positions, adoption and variability regarding eConsent. The benefits of eConsent...

De-risk Go/No Go Product Development Decisions

De-risk Go/No Go Product Development Decisions

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Learn how synthetic controls enable new insights for oncology clinical development and mitigates go/no-go decision risk. Synthetic control data can assist...

Related suppliers

Follow us

Products

View more

Webinars